Mycronic revenue and financials
kr 347.60Change from previous close: −3.18%Absolute change: −kr 11.40
In the fiscal year ended December 2025, Mycronic reported revenue of kr 7.94B (+12.48% year over year). Net income was kr 1.56B, a net margin of 19.7%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +12.48%
- 2025 vs 2024
- Net income growth
- −7.31%
- 2025 vs 2024
- Net margin
- 19.7%
- 2024: 23.8%
Financial data
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total revenue | 2,416 | 2,503 | 2,021 | 2,066 | 2,142 |
| Cost of revenue | 1,042 | 986 | 1,075 | 963 | 832 |
| Gross profit | 1,373 | 1,517 | 945 | 1,103 | 1,310 |
| Selling, general and administrative | 368 | 323 | 331 | 286 | 281 |
| Research and development | 293 | 295 | 277 | 242 | 222 |
| Operating income | 712 | 899 | 342 | 575 | 807 |
| EBIT | 712 | 899 | 342 | 575 | 807 |
| EBITDA | 712 | 899 | 342 | 575 | 807 |
| Pre-tax income | 691 | 919 | 351 | 574 | 786 |
| Income tax | 164 | 204 | 76.0 | 128 | 165 |
| Net income | 527 | 715 | 277 | 446 | 620 |
| Net income to common shareholders | 527 | 715 | 277 | 446 | 620 |
| Basic EPS | 2.70 | 3.66 | 1.42 | 2.28 | 3.18 |
| Diluted EPS | 2.70 | 3.66 | 1.42 | 2.28 | 3.18 |
| Average shares (basic) | 195 | 195 | 195 | 196 | 195 |
| Average shares (diluted) | 195 | 195 | 195 | 196 | 195 |